We read with interest the letter by Durrani et al. addressing large granular lymphocytic leukemia (LGL) coexistence with myeloid clones and myelodysplastic syndromes (MDS). To complement their ...

LGL leukemia represents 2% to 5% of chronic lymphoproliferative disorders in North America and Europe and 5% to 6% in Asia. Recently, the incidence of LGL leukemia has been published from two ...

Large granular lymphocytic (LGL) leukemia is a kind of cancer that affects blood cells. The disease is rare: Only about 1,000 people per year are diagnosed with it. It affects men and women in roughly ...

LGL leukemia is a rare form of blood cancer. It causes a type of white blood cell to mutate and grow out of control. People with slow-growing LGL leukemia may not require treatment for some time.

T-cell large granular lymphocytic (T-LGL) leukemia affects white blood cells called lymphocytes, which are part of the body’s immune system. The “T” means the leukemia starts in T cells. In someone ...